子宫肌瘤患者行子宫肌瘤剔除术对生殖结局的影响:一项回顾性队列研究
单中心回顾性队列研究纳入311例子宫肌瘤女性,165例最终接受子宫肌瘤剔除术,146例继续期待治疗。校正后子宫肌瘤剔除术对活产的风险比为1.26(95%CI 0.87-1.81),敏感性分析结果相似,未发现两组活产时间存在显著差异;期待治疗组更多接受辅助生殖技术(63% vs 38%)。
要点
- 子宫肌瘤剔除术与期待治疗相比,活产时间无显著差异(校正HR 1.26,95%CI 0.87-1.81)。
- 子宫肌瘤剔除术组肌瘤更大(>7 cm:48% vs 15%)且症状更多(85% vs 67%)。
- 期待治疗组更多接受辅助生殖技术(63% vs 38%)。
核心结论
- 在有生育意愿的子宫肌瘤女性中,子宫肌瘤剔除术与期待治疗相比活产时间无显著差异,尽管子宫肌瘤剔除术组的肌瘤更多、更大且症状更明显。
- 子宫肌瘤剔除术后的结果鼓励在大型(有症状)且未或轻微扭曲宫腔的肌瘤、合并不孕或生育意愿的女性中开展随机对照试验。
研究设计与样本
- 单中心回顾性队列研究,纳入311例子宫肌瘤女性,其中165例最终接受子宫肌瘤剔除术,146例继续期待治疗。
- 主要结局为活产时间,采用含子宫肌瘤剔除术时变协变量的Cox比例风险模型评估;敏感性分析结合克隆/删失/加权方法以模拟随机对照试验并校正混杂因素。
主要发现
- 子宫肌瘤剔除术组与期待治疗组基线特征存在明显差异:肌瘤>7 cm者分别为48%和15%;有肌瘤相关主诉者分别为85%和67%。
- 子宫肌瘤剔除术对比期待治疗对活产的校正风险比为1.26(95%CI 0.87-1.81)。
- 敏感性分析结果与主分析相似。
- 次要结局显示,继续期待治疗的女性接受辅助生殖技术的比例(63%)高于最终接受子宫肌瘤剔除术者(38%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the effect of myomectomy in women with uterine fibroids on time to live birth and other reproductive outcomes? DESIGN: This was a monocentric retrospective cohort study of 311 women with fibroids, of whom 165 eventually received myomectomy and 146 remained on expectant management. To assess the primary outcome time to live birth, a Cox proportional hazards model with a time-varying covariate for myomectomy was used. In the sensitivity analyses, this was combined with an approach to account for confounders via a cloning/censoring/weighting that aimed to emulate a randomized controlled trial. RESULTS: Notable differences in baseline characteristics between the myomectomy and expectant management group were fibroid size (fibroid >7 cm: myomectomy 48%; expectant management 15%) and whether the patient had fibroid-related complaints (myomectomy 85%, expectant management 67%). The adjusted hazard ratio for the effect of myomectomy compared with expectant management on live birth was 1.26 (95% CI 0.87-1.81). Sensitivity analyses yielded similar results, but secondary outcomes showed that women remaining on expectant management had more often received assisted reproductive technology (63%) compared with those who eventually received myomectomy (38%). CONCLUSIONS: The study did not find a significant difference in time to live birth after myomectomy compared with expectant management in women with fibroids and a wish to conceive, despite more, larger and more symptomatic fibroids in the myomectomy group. The results after myomectomy encourage the execution of a randomized controlled trial in women with large (symptomatic) fibroids not or minimally distorting the intrauterine cavity, and infertility or a desire to conceive.
引用
- Don EE, Mijatovic V, van Eekelen R, et al. The effect of myomectomy on reproductive outcomes in patients with uterine fibroids: A retrospective cohort study. Reprod Biomed Online. 2022. PMID: 36041962. doi:10.1016/j.rbmo.2022.05.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。